Neeraj Agarwal: Camrelizumab+apatinib in previously treated pts w/ advanced adrenocortical cancer by Zhigong Wei

Neeraj Agarwal shared a post on X:

“Ab#4511 ASCO ASCO 24 by Zhigong Wei. Camrelizumab+apatinib ph2 trial in previously treated pts w/ advanced adrenocortical cancer ORR 52%, DCR 95% promising clinical activity of this combination.”

Read further.
Source: Neeraj Agarwal/X

Neeraj Agarwal is a Professor of Medicine, and a Presidential Endowed Chair of Cancer Research at the Huntsman Cancer Institute (HCI), University of Utah. He also directs the Genitourinary Oncology (GU) Program, and the Center of Investigational Therapeutics (CIT) at the HCI. Dr. Agarwal is an Advisor to the Oncology Drug Advisory Committee and the United States Food and Drug Administration, leads early therapeutics in the SWOG genitourinary cancers committee, and is the Chief Editor of ASCO Daily News..